FDA approves GI View's disposable colonoscope

Aer-O-Scope Photo: PR

The Israeli company's Aer-O-Scope is the first colonoscope to provide a 360 omni-directional visualization of the colon to detect polyps behind folds.

Israeli developer of advanced GI screening systems GI View Ltd. has received US Food and Drug Administration (FDA) 510(k) clearance for its Aer-O-Scope Colonoscope System. Aer-O-Scope is a disposable, self-propelled, joystick-controlled, easy-to-use colonoscope system, with therapeutic access. The new system has two working channels that enable therapeutic access using standard tools, such as snares and forceps, to take biopsies or perform polypectomies.

GI View CEO Tal Simchony said, Todays news marks the achievement of an important regulatory milestone. The new Aer-O-Scope system with therapeutic access has many significant clinical benefits including enabling physicians to more easily, effectively and efficiently identify and remove polyps and prevent colon cancer. We are now working on US market introduction of the Aer-O-Scope. Post market studies are also in the plans.

The Aer-O-Scope is the first colonoscope to provide a 360 omni-directional visualization of the colon to detect polyps behind folds. There is also no risk of contamination or disease transmission between patients from the device as it is to be used only once and then disposed. The Aer-O-Scope employs a soft multi-lumen tube designed to significantly reduce pressure on the colon wall, which in turn, increases patient safety. The tube is also hydrophilic, which reduces the friction between bowel and scope by more than 90%. Patient safety and comfort as well as physician ease of use are further maximized by the systems self-propelled intubation, created using balloons and low pressure CO2 gas. As the system is joystick controlled it is also extremely simple to operate and requires minimal training. Like all colonoscopes, the Aer-O-Scope provides insufflation, irrigation and suction.

Colorectal cancer is one of the biggest causes of cancer death in most countries in the West. This type of cancer can almost always be prevented by early detection and removal of polyps, which if left untouched, can develop into colorectal cancer over a 5-10 year period. More than 690,000 people worldwide die from colorectal cancer annually.

Published by Globes [online], Israel business news - www.globes-online.com - on September 20, 2016

Copyright of Globes Publisher Itonut (1983) Ltd. 2016

Aer-O-Scope Photo: PR
Aer-O-Scope Photo: PR
Twitter Facebook Linkedin RSS Newsletters Israel Business Conference 2018